Cosentyx snrdy 300MG dose-2PENML

Ended Awarded Last action

Contract number
SPE2DR26F7PWR
Awardee
Awarding agency
Obligated
$41,210

Award facts

Contract value 100% obligated
$41,210.10 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, with a ceiling value of $41,210.10 for Cosentyx (cosentinumab) 300 mg dose in 2 mL pen format. Ultimate completion date is February 26, 2026.

Place of performance is Conshohocken, PA. The order was priced firm fixed price and issued without a set-aside under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. This single-award IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.

Quick answers

Who was awarded contract SPE2DR26F7PWR?

SPE2DR26F7PWR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 25, 2026.

How much is contract SPE2DR26F7PWR worth?

The government has obligated $41,210 on SPE2DR26F7PWR.

Is contract SPE2DR26F7PWR an order under another contract?

Yes. SPE2DR26F7PWR is a delivery order under SPE2DR25D7059, an indefinite delivery contract.

Was contract SPE2DR26F7PWR competed?

The extent of competition for SPE2DR26F7PWR was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award